When did Champions Oncology report Q2 2025 earnings?

Champions Oncology (CSBR) reported Q2 2025 earnings on July 23, 2025 after market close.

What were Champions Oncology's Q2 2025 revenue and EPS?

Champions Oncology reported revenue of $12.4M and diluted EPS of $-0.13 for Q2 2025.

Revenue missed the consensus estimate of $14.7M by $2.3M. EPS missed the consensus estimate of $0.06 by $0.19.

Compared to the same quarter a year prior, revenue declined 11.8% from $14.0M a year earlier and diluted EPS declined 1200.0% from $-0.01.

You can read the 10-K periodic report (0001628280-25-035765) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported July 23, 2025 · After market close

Revenue estimate$14.7M

EPS estimate$0.06

Jul 16, 2026 (In 3 weeks)

Revenue estimate$12.9M

EPS estimate-$0.05

Q2 2025$12.4MMiss by $2.3M

Q2 2025-$0.13Miss by $0.19

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Champions Oncology report Q2 2025 earnings?: Champions Oncology (CSBR) reported Q2 2025 earnings on July 23, 2025 after market close.
What were Champions Oncology's Q2 2025 revenue and EPS?: Champions Oncology reported revenue of $12.4M and diluted EPS of $-0.13 for Q2 2025.
Did Champions Oncology beat estimates in Q2 2025?: Revenue missed the consensus estimate of $14.7M by $2.3M. EPS missed the consensus estimate of $0.06 by $0.19.
How did Champions Oncology's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 11.8% from $14.0M a year earlier and diluted EPS declined 1200.0% from $-0.01.
Where can I find Champions Oncology's Q2 2025 SEC filings?: You can read the 10-K periodic report (0001628280-25-035765) directly on SEC EDGAR. The filing index links above go to sec.gov.